Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia
- PMID: 11181864
- PMCID: PMC1737259
- DOI: 10.1136/jnnp.70.3.386
Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia
Abstract
Autoantibodies against glutamic acid decarboxylase (GAD) have been found in stiff-man syndrome, insulin dependent diabetes mellitus, and progressive cerebellar ataxia. A patient with progressive cerebellar ataxia is described who was positive for GAD autoantibodies, and had Sjögren's syndrome. Immunohistochemical studies using CSF and serum samples from the patient showed immunoreactivities in axon terminals of cerebellar GABAergic neurons. A whole cell patch clamp technique recording from rat cerebellar slices showed that the CSF, presumably through GAD autoantibodies, presynaptically inhibited GABAergic transmission. Intravenous administration of immunoglobulin failed to improve clinical symptoms and immunoreactivities examined after therapy. The findings suggest that GAD autoantibodies play a pathogenic part in reducing GABA release in in vitro slices.
Similar articles
-
Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.Ann Neurol. 1999 Aug;46(2):263-7. Ann Neurol. 1999. PMID: 10443895
-
Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase.J Neurol Sci. 2000 Apr 1;175(1):40-4. doi: 10.1016/s0022-510x(00)00272-0. J Neurol Sci. 2000. PMID: 10785255
-
Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.Neurology. 1997 Oct;49(4):1026-30. doi: 10.1212/wnl.49.4.1026. Neurology. 1997. PMID: 9339684
-
[Autoantibodies to GAD and autoimmune-mediated neurological diseases].Nihon Rinsho. 2013 May;71(5):921-6. Nihon Rinsho. 2013. PMID: 23777105 Review. Japanese.
-
Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.Intern Med. 2001 Sep;40(9):968-71. doi: 10.2169/internalmedicine.40.968. Intern Med. 2001. PMID: 11579968 Review.
Cited by
-
Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission.Front Cell Neurosci. 2016 May 18;10:130. doi: 10.3389/fncel.2016.00130. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27242441 Free PMC article.
-
Cognitive Impairment and Celiac Disease: Is Transcranial Magnetic Stimulation a Trait d'Union between Gut and Brain?Int J Mol Sci. 2018 Jul 31;19(8):2243. doi: 10.3390/ijms19082243. Int J Mol Sci. 2018. PMID: 30065211 Free PMC article. Review.
-
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.Ther Adv Neurol Disord. 2021 Mar 30;14:17562864211003486. doi: 10.1177/17562864211003486. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33854562 Free PMC article. Review.
-
Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies.J Neurol. 2002 Mar;249(3):348-50. doi: 10.1007/s004150200019. J Neurol. 2002. PMID: 11993540 No abstract available.
-
Guidelines for treatment of immune-mediated cerebellar ataxias.Cerebellum Ataxias. 2015 Nov 10;2:14. doi: 10.1186/s40673-015-0034-y. eCollection 2015. Cerebellum Ataxias. 2015. PMID: 26561527 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources